Herpes zoster infection in pregnancy: features and consequences.


Journal

Archives of dermatological research
ISSN: 1432-069X
Titre abrégé: Arch Dermatol Res
Pays: Germany
ID NLM: 8000462

Informations de publication

Date de publication:
15 Mar 2024
Historique:
received: 06 02 2024
accepted: 07 02 2024
revised: 06 02 2024
medline: 18 3 2024
pubmed: 15 3 2024
entrez: 15 3 2024
Statut: epublish

Résumé

Herpes (varicella) zoster (HZ) infection occurs in 4 people per 1000 in the general US population (irrespective of prior varicella infection and vaccination status) each year and has been the subject of scientific inquiry for decades. The consequences of infection are myriad and may depend on the dermatome of involvement as well as host factors such as age, comorbidities, prior treatment or immunization, and immunologic status. Pregnancy is associated with an altered immune and hormonal status in the mother. While maternal HZ infection during pregnancy is not uncommon, the implications for both mother and child are not well established, although multiple studies of perinatal maternal HZ infection suggest no intrauterine transmission to the fetus. We review the current literature on herpes zoster infection in pregnancy, including epidemiology, diagnosis, potential immunologic sequelae, and strategies for prevention and treatment.

Identifiants

pubmed: 38489022
doi: 10.1007/s00403-024-02842-3
pii: 10.1007/s00403-024-02842-3
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

107

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Centers for Disease Control and Prevention (CDC) (2020) Shingles (Herpes Zoster). In: Shingles home. Avaliable via https://www.cdc.gov/shingles/hcp/clinical-overview.html#:~:text=Disease%20Rates,-An%20estimated%20one&text=The%20incidence%20for%20herpes%20zoster,per%20100%20U.S.%20population%20annually . Accessed Mar 2024
Schmader K (2018) Herpes zoster. Ann Intern Med 169(3):itc19–itc31. https://doi.org/10.7326/aitc201808070
doi: 10.7326/aitc201808070 pubmed: 30083718
Schafer R, Davis M, Phillippi JC (2019) Herpes zoster in pregnancy. J Midwifery Womens Health 64(2):230–235. https://doi.org/10.1111/jmwh.12953
doi: 10.1111/jmwh.12953 pubmed: 30740856
Enders G, Miller E (2000) Varicella and herpes zoster in pregnancy and the newborn. In: Arvin AM, Gershon AA (eds) Varicella-zoster virus: virology and clinical management. Cambridge University Press, Cambridge, pp 317–348
doi: 10.1017/CBO9780511601194.018
Kennedy PGE, Mogensen TH, Cohrs RJ (2021) Recent issues in varicella-zoster virus latency. Viruses. https://doi.org/10.3390/v13102018
doi: 10.3390/v13102018 pubmed: 34835045 pmcid: 8622816
Kennedy PGE, Gershon AA (2018) Clinical features of varicella-zoster virus infection. Viruses. https://doi.org/10.3390/v10110609
doi: 10.3390/v10110609 pubmed: 30400213 pmcid: 6266119
Gershon AA et al (2015) Varicella zoster virus infection. Nat Rev Dis Primers 1:15016. https://doi.org/10.1038/nrdp.2015.16
doi: 10.1038/nrdp.2015.16 pubmed: 27188665 pmcid: 5381807
Centers for Disease Control and Prevention (CDC) (2021) Zoster. In: Epidemiology and prevention of vaccine-preventable diseases. Avaliable via https://www.cdc.gov/vaccines/pubs/pinkbook/herpes-zoster.html#:~:text=The%20first%20vaccine%20to%20reduce,the%20United%20States%20in%202006 . Accessed Mar 2024
Harpaz R, Ortega-Sanchez I, Seward J (2008) Advisory committee on immunization practices centers for disease C, prevention. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 57(RR-5):1–30
pubmed: 18528318
Gershon M, Gershon A (2018) Varicella-zoster virus and the enteric nervous system. J Infect Dis 218(suppl_2):S113-s119. https://doi.org/10.1093/infdis/jiy407
doi: 10.1093/infdis/jiy407 pubmed: 30247599 pmcid: 6151087
Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ (2000) Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 342(9):635–645. https://doi.org/10.1056/nejm200003023420906
doi: 10.1056/nejm200003023420906 pubmed: 10699164
Reynolds MA, Kruszon-Moran D, Jumaan A, Schmid DS, McQuillan GM (2010) Varicella seroprevalence in the US: data from the National Health and Nutrition Examination Survey, 1999–2004. Public Health Rep 125(6):860–869. https://doi.org/10.1177/003335491012500613
doi: 10.1177/003335491012500613 pubmed: 21121231 pmcid: 2966667
van Oorschot D, Vroling H, Bunge E, Diaz-Decaro J, Curran D, Yawn B (2021) A systematic literature review of herpes zoster incidence worldwide. Hum Vaccin Immunother 17(6):1714–1732. https://doi.org/10.1080/21645515.2020.1847582
doi: 10.1080/21645515.2020.1847582 pubmed: 33651654 pmcid: 8115759
Mor G, Cardenas I (2010) The immune system in pregnancy: a unique complexity. Am J Reprod Immunol 63(6):425–433. https://doi.org/10.1111/j.1600-0897.2010.00836.x
doi: 10.1111/j.1600-0897.2010.00836.x pubmed: 20367629 pmcid: 3025805
Marra F, Parhar K, Huang B, Vadlamudi N (2020) Risk factors for herpes zoster infection: a meta-analysis. Open Forum Infect Dis 7(1):ofaa005. https://doi.org/10.1093/ofid/ofaa005
doi: 10.1093/ofid/ofaa005 pubmed: 32010734 pmcid: 6984676
Lin WC, Wei JC (2023) Long-term risk of herpes zoster following COVID-19: a retrospective cohort study of 2 442 686 patients. J Med Virol 95(7):e28903. https://doi.org/10.1002/jmv.28903
doi: 10.1002/jmv.28903 pubmed: 37386892
Chen YC et al (2023) Long-term risk of herpes zoster following COVID-19: a retrospective cohort study of 2 442 686 patients. J Med Virol 95(4):e28745. https://doi.org/10.1002/jmv.28745
doi: 10.1002/jmv.28745 pubmed: 37185849
Akpandak I, Miller DC, Sun Y, Arnold BF, Kelly JD, Acharya NR (2022) Assessment of herpes zoster risk among recipients of COVID-19 vaccine. JAMA Netw Open 5(11):e2242240–e2242240. https://doi.org/10.1001/jamanetworkopen.2022.42240
doi: 10.1001/jamanetworkopen.2022.42240 pubmed: 36383382 pmcid: 9669817
Saguil A, Kane S, Mercado M, Lauters R (2017) "Herpes zoster and postherpetic neuralgia: prevention and management. Am Fam Phys 96(10):656–663
Russell LK (1992) Management of varicella-zoster virus infection during pregnancy and the peripartum. J Nurse Midwifery 37(1):17–24. https://doi.org/10.1016/0091-2182(92)90018-x
doi: 10.1016/0091-2182(92)90018-x pubmed: 1538264
Sampathkumar P, Drage LA, Martin DP (2009) Herpes zoster (shingles) and postherpetic neuralgia. Mayo Clin Proc 84(3):274–280. https://doi.org/10.1016/s0025-6196(11)61146-4
doi: 10.1016/s0025-6196(11)61146-4 pubmed: 19252116 pmcid: 2664599
Nanthakumar MP, Sood A, Ahmed M, Gupta J (2021) Varicella zoster in pregnancy. Eur J Obstet Gynecol Reprod Biol 258:283–287. https://doi.org/10.1016/j.ejogrb.2021.01.009
doi: 10.1016/j.ejogrb.2021.01.009 pubmed: 33494028
Paryani SG, Arvin AM (1986) Intrauterine infection with varicella-zoster virus after maternal varicella. N Engl J Med 314(24):1542–1546. https://doi.org/10.1056/nejm198606123142403
doi: 10.1056/nejm198606123142403 pubmed: 3012334
Mouly F et al (1997) Prenatal diagnosis of fetal varicella-zoster virus infection with polymerase chain reaction of amniotic fluid in 107 cases. Am J Obstet Gynecol 177(4):894–898
doi: 10.1016/S0002-9378(97)70291-6 pubmed: 9369842
Lamont RF et al (2011) Varicella-zoster virus (chickenpox) infection in pregnancy. BJOG 118(10):1155–1162. https://doi.org/10.1111/j.1471-0528.2011.02983.x
doi: 10.1111/j.1471-0528.2011.02983.x pubmed: 21585641 pmcid: 3155623
Enders G, Miller E, Cradock-Watson J, Bolley I, Ridehalgh M (1994) Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet 343(8912):1548–1551. https://doi.org/10.1016/s0140-6736(94)92943-2
doi: 10.1016/s0140-6736(94)92943-2 pubmed: 7802767
Blumental S, Lepage P (2019) Management of varicella in neonates and infants. BMJ Paediatr Open 3(1):e000433. https://doi.org/10.1136/bmjpo-2019-000433
doi: 10.1136/bmjpo-2019-000433 pubmed: 31263790 pmcid: 6570487
Sauerbrei A, Wutzler P (2001) Neonatal varicella. J Perinatol 21(8):545–549. https://doi.org/10.1038/sj.jp.7210599
doi: 10.1038/sj.jp.7210599 pubmed: 11774017
Centers for Disease Control and Prevention (CDC) (2021) Chickenpox vaccination: what everyone should know. In: Vaccines and preventable diseases. Avaliable via https://www.cdc.gov/vaccines/vpd/varicella/public/index.html . Accessed Mar 2024
ProQuad® [Package insert] (2005) Merck & Co., Inc., Rahway, NJ, USA
Singh T, Otero CE, Li K, Valencia SM, Nelson AN, Permar SR (2020) Vaccines for perinatal and congenital infections-how close are we? Front Pediatr 8:569. https://doi.org/10.3389/fped.2020.00569
doi: 10.3389/fped.2020.00569 pubmed: 33384972 pmcid: 7769834
M. The Centers for Disease Control and Prevention (CDC) (2021) MMRV (Measles, Rubella & Varicella) VIS. In: Vaccine information statements (VISs). Available via https://www.cdc.gov/vaccines/hcp/vis/vis-statements/mmrv.html . Accessed Mar 2024
Gershon AA, Gershon MD, Shapiro ED (2021) Live attenuated varicella vaccine: prevention of varicella and of zoster. J Infect Dis 224(Supplement_4):S387–S397. https://doi.org/10.1093/infdis/jiaa573
doi: 10.1093/infdis/jiaa573 pubmed: 34590140 pmcid: 8482020
Weinmann S et al (2013) Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005–2009. J Infect Dis 208(11):1859–1868. https://doi.org/10.1093/infdis/jit405
doi: 10.1093/infdis/jit405 pubmed: 23922376
Hardy I, Gershon AA, Steinberg SP, LaRussa P (1991) The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group. N Engl J Med 325(22):1545–1550. https://doi.org/10.1056/nejm199111283252204
doi: 10.1056/nejm199111283252204 pubmed: 1658650
American Society for Reproductive Medicine; American College of Obstetricians and Gynecologists' Committee on Gynecologic Practice (2019) Prepregnancy counseling: committee opinion no. 762. Fertil Steril 111(1):32-42. https://doi.org/10.1016/j.fertnstert.2018.12.003 . (PMID: 30611411)
CDC (2022) Guidelines for vaccinating pregnant women. In: pregnancy and vaccination. Available via https://www.cdc.gov/vaccines/pregnancy/hcp-toolkit/guidelines.html#18 . Accessed Mar 2024
Willis ED, Marko AM, Rasmussen SA, McGee M, Broder KR, Marin M (2022) Merck/Centers for disease control and prevention varicella vaccine pregnancy registry: 19-year summary of data from inception through closure, 1995–2013. J Infect Dis 226(Supplement_4):S441-s449. https://doi.org/10.1093/infdis/jiac277
doi: 10.1093/infdis/jiac277 pubmed: 36265854
Hayward K, Cline A, Stephens A, Street L (2018) Management of herpes zoster (shingles) during pregnancy. J Obstet Gynaecol 38(7):887–894. https://doi.org/10.1080/01443615.2018.1446419
doi: 10.1080/01443615.2018.1446419 pubmed: 29565203
Park TH, Chang CH (2012) Keloid recurrence in pregnancy. Aesthetic Plast Surg 36(5):1271–1272. https://doi.org/10.1007/s00266-012-9947-5
doi: 10.1007/s00266-012-9947-5 pubmed: 22890860
Verma SB, Wollina U (2013) Herpes zoster in pregnancy leading to keloids and post herpetic neuralgia: a double whammy? Indian Dermatol Online J 4(2):158–159. https://doi.org/10.4103/2229-5178.110646
doi: 10.4103/2229-5178.110646 pubmed: 23741683 pmcid: 3673390
Casanova Román G, Reyna Figueroa J, Figueroa Damián R, Ortiz Ibarra J (2004) Herpes zoster in immunocompetent pregnant women and their perinatal outcome. Ginecol Obstet Mex 72:63–67
pubmed: 15216903
Miller E, Cradock-Watson JE, Ridehalgh MK (1989) Outcome in newborn babies given anti-varicella-zoster immunoglobulin after perinatal maternal infection with varicella-zoster virus. Lancet 2(8659):371–373. https://doi.org/10.1016/s0140-6736(89)90547-3
doi: 10.1016/s0140-6736(89)90547-3 pubmed: 2569560
Miller E, Marshall R, Vurdien J (1993) Epidemiology, outcome and control of varicella-zoster infection. Rev Med Microbiol 4(4):222–230
doi: 10.1097/00013542-199310000-00006
Quenby S et al (2021) Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss. Lancet 397(10285):1658–1667. https://doi.org/10.1016/s0140-6736(21)00682-6
doi: 10.1016/s0140-6736(21)00682-6 pubmed: 33915094
(2023) Herpes zoster (Shingles). In: Mother to baby | Fact Sheets [Internet]. Organization of teratology information specialists (OTIS), Brentwood (TN), 1994–. (PMID: 35952020)
Higa K, Dan K, Manabe H (1987) Varicella-zoster virus infections during pregnancy: hypothesis concerning the mechanisms of congenital malformations. Obstet Gynecol 69(2):214–222
pubmed: 3027637
Dworkin RH et al (2007) Recommendations for the management of herpes zoster. Clin Infect Dis 44(Suppl 1):S1-26. https://doi.org/10.1086/510206
doi: 10.1086/510206 pubmed: 17143845
Reiff-Eldridge R, Heffner CR, Ephross SA, Tennis PS, White AD, Andrews EB (2000) Monitoring pregnancy outcomes after prenatal drug exposure through prospective pregnancy registries: a pharmaceutical company commitment. Am J Obstet Gynecol 182(1 Pt 1):159–163. https://doi.org/10.1016/s0002-9378(00)70506-0
doi: 10.1016/s0002-9378(00)70506-0 pubmed: 10649172
Stone KM et al (2004) Pregnancy outcomes following systemic prenatal acyclovir exposure: conclusions from the international acyclovir pregnancy registry, 1984–1999. Birth Defects Res A Clin Mol Teratol 70(4):201–207. https://doi.org/10.1002/bdra.20013
doi: 10.1002/bdra.20013 pubmed: 15108247
Pasternak B, Hviid A (2010) Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defects. JAMA 304(8):859–866. https://doi.org/10.1001/jama.2010.1206
doi: 10.1001/jama.2010.1206 pubmed: 20736469
LIDODERM (Lidocaine Patch 5%) [Package insert] (2014) Endo Pharmaceuticals Inc., Malvern, PA
Kim JY, Ko YR, Sim SE, Oh S, Lee MH, Park HJ (2020) Safe drug treatment and procedure for herpes zoster in pregnancy: a case report. Chin Med J (Engl) 133(16):1999–2000. https://doi.org/10.1097/cm9.0000000000000927
doi: 10.1097/cm9.0000000000000927 pubmed: 32826470
Sadati MS, Ahrari I (2014) Severe herpes zoster neuralgia in a pregnant woman treated with acetaminophen. Acta Med Iran 52(3):238–239
pubmed: 24901730
Wong JW, Chin JM, Schlueter RJ (2018) Shingles in pregnancy: an elusive case of left upper quadrant abdominal pain. Hawaii J Med Public Health 77(8):179–182
pubmed: 30083429 pmcid: 6077955
Stanley AY, Durham CO, Sterrett JJ, Wallace JB (2019) Safety of over-the-counter medications in pregnancy. MCN Am J Matern Child Nurs 44(4):196–205. https://doi.org/10.1097/nmc.0000000000000537
doi: 10.1097/nmc.0000000000000537 pubmed: 31033501
FDA (2015) FDA drug safety communication: FDA has reviewed possible risks of pain medicine use during pregnancy. In: Drug safety and avaliability. Avaliable via: https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-has-reviewed-possible-risks-pain-medicine-use-during-pregnancy . Accessed Mar 2024
NEURONTIN® (gabapentin) [package insert]. New York, NY: Pfizer Pharmaceuticals, Inc. December 2020
LYRICA (pregabalin) [package insert]. New York, NY: Pfizer Pharmaceuticals Inc. 2020
Patorno E et al (2020) Gabapentin in pregnancy and the risk of adverse neonatal and maternal outcomes: a population-based cohort study nested in the US medicaid analytic eXtract dataset. PLoS Med 17(9):e1003322. https://doi.org/10.1371/journal.pmed.1003322
doi: 10.1371/journal.pmed.1003322 pubmed: 32870921 pmcid: 7462308
Mostacci B, Poluzzi E, D’Alessandro R, Cocchi G, Tinuper P (2018) Adverse pregnancy outcomes in women exposed to gabapentin and pregabalin: data from a population-based study. J Neurol Neurosurg Psychiatry 89(2):223–224. https://doi.org/10.1136/jnnp-2017-316143
doi: 10.1136/jnnp-2017-316143 pubmed: 28716783
Andrade C (2018) Safety of pregabalin in pregnancy. J Clin Psychiatry. https://doi.org/10.4088/JCP.18f12568
doi: 10.4088/JCP.18f12568 pubmed: 30549500
CDC (2022) Clinical considerations for use of recombinant zoster vaccine (RZV, Shingrix) in immunocompromised adults aged ≥ 19 years. In: Shingles (Herpes Zoster). Available via https://www.cdc.gov/shingles/vaccination/immunocompromised-adults.html . Accessed Mar 2024

Auteurs

Amit Singal (A)

Rutgers New Jersey Medical School, Newark, NJ, USA.

Robert A Schwartz (RA)

Dermatology and Pathology, Rutgers New Jersey Medical School, 185 South Orange Avenue, Newark, NJ, 07103, USA. roschwar@rutgers.edu.

Chinmoy Bhate (C)

Dermatology and Pathology, Rutgers New Jersey Medical School, 185 South Orange Avenue, Newark, NJ, 07103, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH